Four Vanderbilt technologies earned patent protection from the USPTO in December, bringing the total number of patents assigned to Vanderbilt to 23 for the first half of FY14.
Michael Best and Freidrich, LLP, will host a free webinar to discuss new FDA guidelines and their scope of enforcement discretion on medical software applications designed for mobile devices.
Three Vanderbilt technologies received US patent protection in the month of November. One invention includes a compound that targets positive allosteric modulation of the mGlu5 receptor for the treatment of neurological and psychiatric disorders. It was developed at Vanderbilt Center for Neuroscience Drug Discovery which is led by Vanderbilt neuroscientist P.
InvisionHeart, a young Vanderbilt startup, has secured funding and, this week, signed a license agreement with Vanderbilt University regarding the technology that underlies the company’s business.
The week of Dec. 9 - 13 will be a busy one for Vanderbilt innovators and entrepreneurs with talks on entrepreneurial opportunities for physicians, risk reduction in life sciences companies, and a symposium on surgery and engineering.
What if there was a program that connected surgeons, physicians, nursing staff, and other medical care providers with a team of the nation’s top engineers?